ConductScience.org, home

Paper9813751

Multicenter trial on prognostic value of inducible ischemia, assessed by dobutamine stress echocardiography and exercise electrocardiography test, in patients with uncomplicated myocardial infarction, treated with thrombolytic therapy.

Galati A and 12 others. Int J Card Imaging, 1998. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Multicenter trial on prognostic value of inducible ischemia, assessed by dobutamine stress echocardiography and exercise electrocardiography test, in patients with uncomplicated myocardial infarction, treated with thrombolytic therapy. Papers, record 9813751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9813751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multicenter trial on prognostic value of inducible ischemia, assessed by dobutamine stress echocardiography and exercise electrocardiography test, in patients with uncomplicated myocardial infarction, treated with thrombolytic therapy.
PubMed
Journal
Int J Card Imaging
PubMed
Year
1998
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2026-10-16
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Galati AA
2Bigi RR
3Coletta CC
4Fiorentini CC
5Ricci RR
6Occhi GG
7Sestili AA
8Rulli FF
9Aspromonte NN
10Fera MSM S
11Greco GG
12Guagnozzi GG
13Ceci VV

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DobutamineMajor topic
EchocardiographyMajor topic
ElectrocardiographyMajor topic
Myocardial InfarctionMajor topic
Thrombolytic TherapyMajor topic
Exercise Test
Female
Fibrinolytic Agents
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Ischemia
Predictive Value of Tests
Prognosis
Risk Assessment
Sensitivity and Specificity
Streptokinase
Time Factors
Tissue Plasminogen Activator

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12563896
Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.
N Engl J Med1989https://conductscience.org/library/papers/2563896PubMed
27094264Prognostic value of exercise testing, coronary angiography and left ventriculography 6--8 weeks after myocardial infarction.Circulation1982https://conductscience.org/library/papers/7094264PubMed
37560613Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function.J Am Coll Cardiol1995https://conductscience.org/library/papers/7560613PubMed
48279348Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis.Am J Cardiol1993https://conductscience.org/library/papers/8279348PubMed
52407955Prognosis and management after a first myocardial infarction.N Engl J Med1990https://conductscience.org/library/papers/2407955PubMed
67658777Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto.Lancet1995https://conductscience.org/library/papers/7658777PubMed
72584547Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands.J Am Coll Cardiol1989https://conductscience.org/library/papers/2584547PubMed
82123901Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group.J Am Coll Cardiol1990https://conductscience.org/library/papers/2123901PubMed
98666176[Prognostic value of echo-dobutamine test in patients with ischemic heart disease: comparison with exercise test].G Ital Cardiol1996https://conductscience.org/library/papers/8666176PubMed
108077528
Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) Data Base.
J Am Coll Cardiol1994https://conductscience.org/library/papers/8077528PubMed
117923654Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling.Circulation1994https://conductscience.org/library/papers/7923654PubMed
12460322Prognostic value of exercise testing soon after myocardial infarction.N Engl J Med1979https://conductscience.org/library/papers/460322PubMed
138259778Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group.Am J Med1993https://conductscience.org/library/papers/8259778PubMed
149014976Prognostic value of dobutamine echocardiography early after uncomplicated acute myocardial infarction: a comparison with exercise electrocardiography.J Am Coll Cardiol1997https://conductscience.org/library/papers/9014976PubMed
151564221Dobutamine stress echocardiography for detection and assessment of coronary artery disease.J Am Coll Cardiol1992https://conductscience.org/library/papers/1564221PubMed
161990780Risk stratification in survivors of acute myocardial infarction: routine cardiac catheterization and angiography is a reasonable approach in most patients.Am Heart J1991https://conductscience.org/library/papers/1990780PubMed
172698218
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.
J Am Soc Echocardiogr1989https://conductscience.org/library/papers/2698218PubMed
188088274Dipyridamole echocardiographic test performed 3 days after an acute myocardial infarction: feasibility, tolerability, safety and in-hospital prognostic value.Eur Heart J1994https://conductscience.org/library/papers/8088274PubMed
196861310Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography.Circulation1983https://conductscience.org/library/papers/6861310PubMed
202754124High dose dipyridamole echocardiography early after uncomplicated acute myocardial infarction: correlation with exercise testing and coronary angiography.J Am Coll Cardiol1989https://conductscience.org/library/papers/2754124PubMed

See all 37 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9813751

GET https://conductscience.org/api/papers/v1/9813751/references?page=2